NESP

BIOLOGICAL2 trials

Sponsors

Genexine, Inc., Chong Kun Dang Pharmaceutical

Conditions

AnemiaAnemia of Chronic Kidney DiseaseChronic Kidney Disease

Phase 2

Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)

CompletedNCT02044653

Genexine, Inc.Anemia, Chronic Kidney Disease

Start: 2014-04-15End: 2017-04-20Updated: 2017-10-16

Phase 3

CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis

CompletedNCT03428594

Chong Kun Dang PharmaceuticalAnemia of Chronic Kidney Disease

Start: 2015-06-30End: 2017-06-30Updated: 2018-02-09